The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors

Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have been proposed, but only one of them (the IPSET-t...

Full description

Bibliographic Details
Published in:	Advances in Hematology
Main Authors:	Salvatrice Mancuso, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo, Sergio Siragusa
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Online Access:	http://dx.doi.org/10.1155/2020/9124821

Similar Items

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
by: Vincenzo Accurso, et al.
Published: (2020-01-01)

Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
by: Vincenzo Accurso, et al.
Published: (2019-12-01)

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
by: Vincenzo Accurso, et al.
Published: (2019-03-01)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01)

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
by: A. A. Zhernyakova, et al.
Published: (2017-06-01)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
by: Ivan Krecak, et al.
Published: (2023-11-01)

Acute thrombotic complication of essential thrombocythemia
by: Selami Koçak Toprak, et al.
Published: (2011-12-01)

PB2241: THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES
by: Arij Cheffai, et al.
Published: (2023-08-01)

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia
by: Agnès Charpentier, et al.
Published: (2016-09-01)

Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma
by: Melania Carlisi MD, et al.
Published: (2024-01-01)

Immunosenescence and lymphomagenesis
by: Salvatrice Mancuso, et al.
Published: (2018-09-01)

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia
by: Valerio De Stefano, et al.
Published: (2009-05-01)

Acute thrombotic complication of essential thrombocythemia in a young adult
by: Selami Koçak Toprak, et al.
Published: (2011-12-01)

Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain
by: Panayiotis D. Ziakas
Published: (2008-09-01)

The Association Between Gene Polymorphisms and Leukocytosis with Thrombotic Complications in Patients with Essential Thrombocythemia and Polycythemia Vera
by: Özgür Mehtap, et al.
Published: (2012-05-01)

Low-Risk Essential Thrombocythemia: A Comprehensive Review
by: Andrew J. Robinson, et al.
Published: (2021-02-01)

Essential Thrombocythemia
by: Kanchanee Janwanitsthaporn
Published: (2002-08-01)

Correction Notice: Low-risk Essential Thrombocythemia: A Comprehensive Review
Published: (2022-02-01)

Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events
by: Pirun Saelue MD, PhD, et al.
Published: (2024-06-01)

Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report
by: Chunmei Qin, et al.
Published: (2023-05-01)

Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey
by: Napolitano M, et al.
Published: (2020-07-01)

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
by: Valerio De Stefano, et al.
Published: (2008-03-01)

A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations
by: Hanna Janiszewska, et al.
Published: (2012-03-01)

Essential thrombocythemia: Busulphan revisited
by: Prasad R Koduri
Published: (2016-01-01)

Ruxolitinib for the Treatment of Essential Thrombocythemia
by: Arief Gunawan, et al.
Published: (2018-08-01)

Neurological disorders in essential thrombocythemia
by: Segolene Billot, et al.
Published: (2011-12-01)

Myelofibrotic transformation in essential thrombocythemia
by: Juergen Thiele, et al.
Published: (2009-03-01)

Emerging treatments for essential thrombocythemia
by: Okoli S, et al.
Published: (2011-12-01)

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
by: Alberto Alvarez-Larrán, et al.
Published: (2016-08-01)

Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview
by: Luca Pipitò, et al.
Published: (2023-08-01)

PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
by: Yun Hui Hwang, et al.
Published: (2023-08-01)

Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps
by: Salvatrice Mancuso, et al.
Published: (2024-02-01)

MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan
by: Chiho Furuya, et al.
Published: (2023-12-01)

Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia
by: Young Hoon Park, et al.
Published: (2023-04-01)

The Levels of Adhesion Molecules in Essential Thrombocythemia
by: Oktay Bilgir, et al.
Published: (2014-08-01)

Essential thrombocythemia presenting as digital ischemia
by: Md. Nazmul Hasan, et al.
Published: (2017-09-01)

The role of oxidative stress in essential thrombocythemia
by: Cornel Moisă, et al.
Published: (2018-03-01)

Moyamoya syndrome in an adult with essential thrombocythemia
by: Marc Lazzaro, et al.
Published: (2011-04-01)

The Lower Extremity Ulcer, Mimicking Vascular Symptoms Due to Essential Thrombocythemia
by: Fatih Ada, et al.
Published: (2014-08-01)

Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients
by: Francesca Palandri, et al.
Published: (2010-06-01)